|
⚲
|
| Keyboard |
| Clarke C Boyd
✚
|
|
|---|---|
| CIK # | 0001604456, 0001182504 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001182504] | |
| 3 | [0001604456] | |
| 4 | [0001604456] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Clarke C Boyd | |
| Aldeyra Therapeutics Inc | |
| Clarke C Boyd | |
| Novelion Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aldeyra Therapeutics Inc ALDX
Employee Stock Option (Right to Buy) · derivative
|
2016-06-09 | Grant | 6,083 | $0.00 | |
|
Aldeyra Therapeutics Inc ALDX
Employee Stock Option (Right to Buy) · derivative
|
2015-06-09 | Grant | 6,083 | $0.00 | |
|
Aldeyra Therapeutics Inc ALDX
Common Stock
|
2014-08-06 | Buy | 3,000 | $3.69 | 11,070 |
|
Aldeyra Therapeutics Inc ALDX
Common Stock
|
2014-05-07 | Buy | 12,500 | $8.00 | 100,000 |
|
Aldeyra Therapeutics Inc ALDX
Employee Stock Option (Right to Buy) · derivative
|
2014-05-07 | Grant | 18,250 | $0.00 | |
|
Novelion Therapeutics Inc QLTI
Common Stock
|
2012-07-09 | Sell | 20,000 | $7.62 | 152,400 |
|
Novelion Therapeutics Inc QLTI
Common Stock
|
2012-07-09 | Sell | 55,450 | $7.62 | 422,529 |
|
Novelion Therapeutics Inc QLTI
Common Stock
|
2012-06-06 | Gift | 20,000 | $0.00 | |
|
Novelion Therapeutics Inc QLTI
Common Stock
|
2012-05-15 | Buy | 2,450 | $6.56 | 16,072 |